Highly Effective Detection of Human Papillomavirus 16 and 18 DNA by a Testing Algorithm Combining Broad-Spectrum and Type-Specific PCR

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Clinical Microbiology

• Publication date

  2006-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JCM.00539-06PMID 16954263PMCID PMC1594708
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human Papillomaviruses

  2006cited by this paper
• Carcinogenicity of human papillomaviruses.

  2005cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.

  2005cited by this paper
• Detection of persistent high risk human papillomavirus infections with hybrid capture II and SPF10/LiPA.

  2005cited by this paper
• Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.

  2004cited by this paper
• Viral load as a predictor of the risk of cervical intraepithelial neoplasia

  2003cited by this paper
• Epidemiologic classification of human papillomavirus types associated with cervical cancer.

  2003cited by this paper
• The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity

  2003cited by this paper
• Persistence and load of high‐risk HPV are predictors for development of high‐grade cervical lesions: A longitudinal French cohort study

  2003cited by this paper
• Use of PGMY Primers in L1 Consensus PCR Improves Detection of Human Papillomavirus DNA in Genital Samples

  2002cited by this paper
• High Prevalence of Human Papillomavirus (HPV) Infections and High Frequency of Multiple HPV Genotypes in Human Immunodeficiency Virus-Infected Women in Brazil

  2002cited by this paper
• A controlled trial of a human papillomavirus type 16 vaccine.

  2002cited by this paper
• Genotyping of Human Papillomavirus in Liquid Cytology Cervical Specimens by the PGMY Line Blot Assay and the SPF10 Line Probe Assay

  2002cited by this paper
• GP5+/6+ PCR followed by Reverse Line Blot Analysis Enables Rapid and High-Throughput Identification of Human Papillomavirus Genotypes

  2002cited by this paper
• Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study.

  2001cited by this paper
• Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction.

  2001cited by this paper
• Piffalls in diagnostic molecular pathology--significance of sampling error.

  2001cited by this paper
• Molecular detection and genotyping of human papillomavirus

  2001cited by this paper
• Improved Amplification of Genital Human Papillomaviruses

  2000cited by this paper
• Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study.

  2000cited by this paper
• Comparison between hybrid capture II and polymerase chain reaction results among women at low risk for cervical cancer.

  2000cited by this paper
• Development and Clinical Evaluation of a Highly Sensitive PCR-Reverse Hybridization Line Probe Assay for Detection and Identification of Anogenital Human Papillomavirus

  1999influential reference
• Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

  1999influential reference
• A systematic review of the role of human papillomavirus testing within a cervical screening programme.

  1999cited by this paper
• Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Products by a Single-Hybridization, Reverse Line Blot Detection Method

  1998cited by this paper
• Technical Advance Novel Short-Fragment PCR Assay for Highly Sensitive Broad-Spectrum Detection of Anogenital Human Papillomaviruses

  1998cited by this paper
• A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings

  1997cited by this paper
• PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems

  1997cited by this paper
• Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas

  1996cited by this paper
• The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR.

  1995cited by this paper
• Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy

  1995cited by this paper
• Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance.

  1995cited by this paper
• Human papillomaviruses.

  1994cited by this paper
• Persistence of type-specific human papillomavirus infection among cytologically normal women.

  1994cited by this paper
• Polymerase chain reaction-based methods for the detection of human papillomavirus DNA.

  1992cited by this paper
• Basic local alignment search tool.

  1990cited by this paper
• Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

  1988cited by this paper

• HPV genotype prevalence in low- and high-vaccine coverage, USA populations: Data from real-world cervical cancer screening using the Onclarity HPV assay.

  2026cites this paper
• HPV genotyping agreement between paired cervical cytological sample and biopsy across lesion severity and vaccination

  2025cites this paper
• Detection of Human Papillomavirus (HPV) in HPV-Associated Oropharyngeal Squamous Cell Carcinoma: A Review of Diagnostic Approach and Its Importance for the Head and Neck Oncologist

  2025cites this paper
• Electrochemical biosensors for Human Papilloma Virus (HPV) detection.

  2025cites this paper
• Human papillomavirus type 16 and 18 viral clearance and progression to precancer among women aged 18–25 years enrolled in the Costa Rica HPV prophylactic vaccine trial (CVT)

  2025cites this paper
• Epidemiological distribution of high-risk human papillomavirus genotypes and associated factors among patients with esophageal carcinoma at Bugando medical center in Mwanza, Tanzania

  2024cites this paper
• Predictable changes in the accuracy of human papillomavirus tests after vaccination: review with implications for performance monitoring in cervical screening

  2024cites this paper
• The Next Chapter in Cancer Diagnostics: Advances in HPV-Positive Head and Neck Cancer

  2024cites this paper
• Human papillomavirus spectrum of HPV-infected women in Nigeria: an analysis by next-generation sequencing and type-specific PCR

  2023cites this paper
• Analysis of publications on HPV genotype co-infection: a bibliometric study on existing research

  2023cites this paper
• Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus–Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

  2022cites this paper
• Analysis of cervical HPV infections among unvaccinated young adult women to inform vaccine strategies in this age group: the Costa Rica HPV Vaccine Trial

  2022cites this paper
• Head‐to‐head comparison of genotyping of human papillomavirus by GP5+/6+‐PCR‐based reverse dot blot hybridization assay and SPF10‐PCR‐based line probe assay

  2022cites this paper
• Comparative analysis of different PCR‐based strategies for HPV detection and genotyping from cervical samples

  2021cites this paper
• Recent Progress in Electrochemical Detection of Human Papillomavirus (HPV) via Graphene-Based Nanosensors

  2021cites this paper
• Evidence for missing HPV-45 and -59 positives with the SPF10-DEIA-LiPA25 (version 1) platform compared to the type-specific qPCR assays and the impact on vaccine effectiveness estimates

  2020cites this paper
• HPV Vaccination: The Position Paper of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV)

  2020cites this paper
• Molecular and pathological basis of HPV‐negative cervical adenocarcinoma seen in a global study

  2020cites this paper
• Developing and Standardizing Human Papillomavirus Tests

  2020cites this paper
• Risk Factors for NON-HPV16/18 Cervical Infections and Associated Lesions Among HPV-DNA-Negative Women Vaccinated Against HPV16/18 in the Costa Rica Vaccine Trial (CVT).

  2020cites this paper
• Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial.

  2020cites this paper
• Evidence for Missing Positive Results for Human Papilloma Virus 45 (HPV-45) and HPV-59 with the SPF10-DEIA-LiPA25 (Version 1) Platform Compared to Type-Specific Real-Time Quantitative PCR Assays and Impact on Vaccine Effectiveness Estimates

  2020cites this paper
• Efficacy of the AS04-adjuvanted HPV-16/18 vaccine: Pooled analysis of the Costa Rica Vaccine and PATRICIA randomized controlled trials.

  2019cites this paper
• Prevalence and Incidence of Human Papillomavirus (HPV) Infection Before and After Pregnancy: Pooled Analysis of the Control Arms of Efficacy Trials of HPV-16/18 AS04-Adjuvanted Vaccine

  2019cites this paper
• Recurrent disease after treatment for cervical pre-cancer: determining whether prophylactic HPV vaccination could play a role in prevention of secondary lesions

  2019cites this paper
• Efficacy, immunogenicity and safety of the AS04‐HPV‐16/18 vaccine in Chinese women aged 18‐25 years: End‐of‐study results from a phase II/III, randomised, controlled trial

  2019cites this paper
• Molecular characterization of HPV infection: Evaluation of vaccine effects, viral diversity and variant development

  2019influential citation
• HPV infections and cytologic abnormalities in vaccinated women 21-34 years of age: Results from the baseline phase of the Onclarity trial.

  2019cites this paper
• Whole tissue cervical mapping of HPV infection: Molecular evidence for focal latent HPV infection in humans

  2019cites this paper
• Effect of the bivalent HPV vaccine on viral load of vaccine and non-vaccine HPV types in incident clearing and persistent infections in young Dutch females

  2019cites this paper
• The history of organized screening programs

  2018cites this paper
• Review of the current published evidence for single-dose HPV vaccination: White paper

  2018influential citation
• Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies

  2018cites this paper
• A large-scale immunoinformatics analysis of the human papillomaviruses reveals a common E5 oncoprotein-pattern to evade the immune response

  2018cites this paper
• Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial

  2018cites this paper
• Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors

  2018cites this paper
• The Variable Characteristics of Human Papillomavirus in Squamous Cell Carcinoma and Adenocarcinoma of Cervix in China

  2018cites this paper
• Natural history of human papillomavirus infection of sun-exposed healthy skin of immunocompetent individuals over three climatic seasons and identification of HPV209, a novel betapapillomavirus.

  2017cites this paper
• Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials

  2017cites this paper
• HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis.

  2017cites this paper
• Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors

  2017cites this paper
• Implications de l'hétérogénéité comportementale et biologique pour la vaccination contre les virus du papillome humain au niveau de la population : modélisation mathématique, revue systématique et méta-analyse

  2016cites this paper
• Prior human papillomavirus‐16/18 AS04‐adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post‐hoc analysis from a randomized controlled trial

  2016cites this paper
• The variable clinicopathological categories and role of human papillomavirus in cervical adenocarcinoma: A hospital based nation‐wide multi‐center retrospective study across China

  2016cites this paper
• Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseases

  2016influential citation
• The complex relationship between human papillomavirus and cervical adenocarcinoma

  2016cites this paper
• Potential applications of polyoxometalates for the discrimination of human papillomavirus in different subtypes.

  2016cites this paper
• Comparison of Two Widely Used Human Papillomavirus Detection and Genotyping Methods, GP5+/6+-Based PCR Followed by Reverse Line Blot Hybridization and Multiplex Type-Specific E7-Based PCR

  2016cites this paper
• Human papillomavirus detection in fine needle aspiration cytology of lymph node metastasis of head and neck squamous cell cancer.

  2016cites this paper
• Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment

  2016cites this paper
• Positive effect of HPV status on prognostic value of blood lymphocyte-to-monocyte ratio in advanced cervical carcinoma

  2016cites this paper
• Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study.

  2016cites this paper
• Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study

  2016cites this paper
• Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection.

  2016cites this paper
• Efficacy, immunogenicity, and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in Chinese women aged 18–25 years: event‐triggered analysis of a randomized controlled trial

  2016cites this paper
• Cervical Cancer Screening at a Crossroads: Learnings from the Past Driving Change for the Future

  2016cites this paper
• Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-Adjuvanted Vaccine against Cervical Infection and Precancer in Young Women: Final Event-Driven Analysis of the Randomized, Double-Blind PATRICIA Trial

  2015cites this paper
• Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica.

  2015cites this paper
• The epidemiology of human papillomavirus in HIV-negative and HIV-infected men who have sex with men

  2015cites this paper
• Chapter 12 No evidence for a protective eff ect of naturally induced HPV antibodies on subsequent anogenital HPV infection in HIV-negative and HIV-infected MSM

  2015cites this paper
• Matching intended use and type of HPV test in research and clinical practice

  2015influential citation
• Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methods

  2015cites this paper
• Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.

  2015cites this paper
• The original SPF10 LiPA25 algorithm is more sensitive and suitable for epidemiologic HPV research than the SPF10 INNO-LiPA Extra.

  2015cites this paper
• Title : Investigating Diagnostic Problems of CIN 1 and 2 Associated with High-Risk HPV by Combining the Novel Molecular Biomarker PanHPV E 4 with P 16 ink 4 a

  2015cites this paper
• A critical analysis of the Australian government’s rationale for its vaccination policy

  2015cites this paper
• Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a

  2015cites this paper
• TEMPORARY REMOVAL: The original SPF10 LiPA25 algorithm is more sensitive and suitable for epidemiologic HPV research than the SPF10 INNO-LiPA Extra.

  2014cites this paper
• Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial

  2014cites this paper
• HIV-Negative and HIV-Infected MSM HPV Seroconversion Following Anal and Penile HPV Infection in Updated

  2014cites this paper
• Cross-sectional study of genital carcinogenic HPV infections in Paramaribo, Suriname: prevalence and determinants in an ethnically diverse population of women in a pre-vaccination era

  2014cites this paper
• Human papillomavirus prevalence and type-distribution in women with cervical lesions: a cross-sectional study in Sri Lanka

  2014cites this paper
• Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub‐Saharan Africa

  2014cites this paper
• Human papillomavirus prevalence and type distribution among women attending routine gynecological examinations in Saudi Arabia

  2014cites this paper
• Post Hoc Analysis of the PATRICIA Randomized Trial of the Efficacy of Human Papillomavirus Type 16 (HPV-16)/HPV-18 AS04-Adjuvanted Vaccine against Incident and Persistent Infection with Nonvaccine Oncogenic HPV Types Using an Alternative Multiplex Type-Specific PCR Assay for HPV DNA

  2014cites this paper
• An epidemiological study assessing the prevalence of human papillomavirus types in women in the Kingdom of Bahrain

  2014cites this paper
• HPV Seroconversion Following Anal and Penile HPV Infection in HIV-Negative and HIV-Infected MSM

  2014cites this paper
• Clinical Evaluation of a GP5+/6+-Based Luminex Assay Having Full High-Risk Human Papillomavirus Genotyping Capability and an Internal Control

  2014cites this paper
• Type distribution of human papillomavirus among adult women diagnosed with invasive cervical cancer (stage 1b or higher) in New Zealand

  2014cites this paper
• Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18–25 years enrolled in a clinical trial

  2014cites this paper
• Reduced prevalence of vulvar HPV16/18 infection among women who received the HPV16/18 bivalent vaccine: a nested analysis within the Costa Rica Vaccine Trial.

  2014cites this paper
• Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine

  2014cites this paper
• Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18–25 years: Results from a randomized controlled trial

  2014cites this paper
• Risk of Newly Detected Infections and Cervical Abnormalities in Women Seropositive for Naturally Acquired Human Papillomavirus Type 16/18 Antibodies: Analysis of the Control Arm of PATRICIA

  2014cites this paper
• Human papillomavirus infection is rare in nonmalignant tonsil tissue in the UK: Implications for tonsil cancer precursor lesions

  2014cites this paper
• Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study.

  2014cites this paper
• Evaluation of the HPV typing INNO-LiPA EXTRA assay on formalin-fixed paraffin-embedded cervical biopsy samples.

  2014cites this paper
• Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical intraepithelial neoplasia and cervical infection in young Japanese women

  2014cites this paper
• Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testing.

  2014cites this paper
• No evidence for a protective effect of naturally induced HPV antibodies on subsequent anogenital HPV infection in HIV-negative and HIV-infected MSM.

  2014cites this paper
• and persistent infection with non-vaccine oncogenic HPV types using an alternative

  2014cites this paper
• Caracterización y dinámica de los patrones de infecciones únicas y múltiples para seis tipos del virus de papiloma humano de alto riesgo

  2014cites this paper
• Evaluation of an automated SPF10-LiPA25 assay for detection and typing of human papillomavirus in archival samples.

  2014cites this paper
• UvA-DARE ( Digital Academic Repository ) Molecular epidemiology of Chlamydia trachomatis

  2014cites this paper
• Cervical cancers associated with human papillomavirus types 16, 18 and 45 are diagnosed in younger women than cancers associated with other types: a cross-sectional observational study in Wales and Scotland (UK).

  2013cites this paper
• Efficacy of the HPV-16/18 AS04-Adjuvanted Vaccine Against Low-Risk HPV Types (PATRICIA Randomized Trial): An Unexpected Observation

  2013cites this paper
• Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses

  2013cites this paper
• HPV vaccination programs have not been shown to be cost-effective in countries with comprehensive Pap screening and surgery

  2013cites this paper
• HPV genotypes in invasive cervical cancer in Danish women

  2013cites this paper
• Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination.

  2013cites this paper